VA loma linda radiopharmaceuticals OY1 do
Ended Awarded Last action
- Contract number
- 36C26226N0010
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $469,120
Award facts
- Contract value 100% obligated
- $469,120.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Loma Linda, CA 92357, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $469,120 |
About this award
Jubilant Draximage Radiopharmacies, Inc., operating as Jubilant Radiopharma, was awarded a delivery order valued at $469,120.30 by Veterans Integrated Service Network 22 (VISN 22) on October 1, 2025, for the supply of radiopharmaceuticals to the VA Loma Linda medical facility in California. The contract is structured as a firm fixed-price delivery order with no small business set-aside designation and extends through September 30, 2026. Jubilant Radiopharma is a for-profit, self-certified small disadvantaged business specializing in the manufacturing and distribution of radiopharmaceuticals and nuclear medicine products, including diagnostic imaging agents and therapeutic radioisotopes used in procedures such as positron emission tomography scans and cardiac imaging.
This delivery order is issued under one of Jubilant Radiopharma's existing Indefinite Delivery/Indefinite Quantity contracts with the VA, through which the company supplies a comprehensive range of radiopharmaceutical products including fluorine-18 fluorodeoxyglucose, iodine-123, technetium-99m, gallium-67 citrate, and other medical isotopes to support critical nuclear medicine diagnostics and treatment capabilities across VA medical facilities nationwide. The company maintains multiple IDI/IQ vehicles with various VISNs, with the largest valued at approximately $39.8 million, reflecting the VA's significant reliance on Jubilant Radiopharma as a key supplier of specialized radiopharmaceutical materials.
Quick answers
Who was awarded contract 36C26226N0010?
36C26226N0010 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C26226N0010 worth?
The government has obligated $469,120 on 36C26226N0010.
Is contract 36C26226N0010 an order under another contract?
Yes. 36C26226N0010 is a delivery order under 36C26225D0004, an indefinite delivery contract.
Was contract 36C26226N0010 competed?
The extent of competition for 36C26226N0010 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award